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eurysm Repair in an Experimental Model Using Human Cadaveric Aortas
Melas N., Saratzis A., Saratzis N., Lazaridis J., Psaroulis D., Trygonis K.,
Kiskinis D. Eur J Vasc Endovasc Surg 2010;40;in press.
Objective: To evaluate the proximal and distal (iliac) fixation of seven
self-expanding endografts, used in the endovascular treatment (EVAR) of
abdominal-aortic aneurysm (AAA), by measuring the displacement force
(DF) necessary to dislocate the devices from their fixation sites.
Methods: A total of 20 human cadaveric aortas were exposed, left in
situ and transected to serve as fixation zones. The Anaconda, EndoFit
aorto-uni-iliac, Endurant, Powerlink, Excluder, Talent and Zenith stent
grafts were deployed and caudal force was applied at the flow divider,
through a force gauge. The DF needed to dislocate each device  20 mm
from the infrarenal neck was recorded before and after moulding-balloon
dilatation. Cephalad force was similarly applied to each iliac limb to assess
distal fixation before and after moulding-balloon dilatation.
Results: Endografts with fixation hooks or barbs displayed a signifi-
cantly higher DF necessary to dislocate the proximal portion compared with
devices with no such fixation modalities (p  0.001). Balloon dilatation
produced a significant increase in DF in both devices with (p  0.001) or
without (p  0.003) hooks or barbs. Suprarenal support did not enhance
proximal fixation (p  0.90). Balloon dilatation significantly increased the
DF necessary to dislodge the iliac limbs (p  0.007).
Conclusions: Devices with fixation hooks displayed higher proximal
fixation. Moulding-balloon dilatation increased proximal and distal fixation.
Suprarenal support did not affect proximal fixation.
Abdominal Aortic Aneurysm Surgery in Renal, Cardiac and Hepatic
Transplant Recipients
SadatU.,Huguet E.L., Varty K. Eur J Vasc Endovasc Surg 2010;40;in press.
With advancements in transplantation and improved long-term allo-
graft survival, the once rare clinical scenario of an abdominal aortic aneurysm
(AAA) in a patient with a functioning allograft has become much more
frequent. In transplant recipients, AAA repair has the potential to cause
irreversible ischaemic injury to the transplanted organ. Different case series
and case reports have mentioned a variety of techniques to offer protection
to the transplanted organs during aneurysm repair such as cold perfusion,
shunting, temporary surgical bypass and extracorporeal circuits etc. Critical
review of these adjuncts seems to suggest that that they do not give any
better results than just using a “clamp and go” approach. Endovascular
aneurysm repair (EVAR)may offer some advantages for transplant patients who
have suitable anatomy for endovascular stent deployment. In addition to these
surgical techniques, various aspects of medical management for renal, cardiac
and hepatic transplant recipients undergoing AAA repair are discussed.
Carotid Endarterectomy for Symptomatic, but “Haemodynamically
Insignificant” Carotid Stenosis
Ahmed R.M., Harris J.P., Anderson C.S., MakehamV., Halmagyi G.M. Eur
J Vasc Endovasc Surg 2010;40;in press.
Objective: Carotid endarterectomy (CEA) guidelines in symptomatic
carotid stenosis are based on NASCET and ECST criteria with 70% or
greater carotid stenosis as estimated from a catheter angiogram the major
indication. This has several problems: (1) lack of reliable correlation between
non-invasive imaging and catheter angiography, which has been largely
superseded by non-invasive imaging in investigating carotid stenosis; (2)
errors inherent in estimating the degree of stenosis from catheter angiogra-
phy; (3) disregard for the fact that stroke risk also depends on plaque
stability, and number of ischaemic events.
Methods: A retrospective review of ischaemic events, imaging results,
operative findings, surgical complications and stroke-free follow-up in 31 pa-
tients presenting over a 23 year period with TIA/stroke (symptoms lasting
 24 h and/or imaging evidence of infarction) who had 70% or less carotid
stenosis (on non-invasive imaging), but nonetheless underwent CEA.
Results: Nineteen patients had small strokes, 7 had TIAs and 5 hadReaders can access EJVES articles at http://intl.e
1114ruptured plaque at CEA. One patient suffered an intra-operative stroke, only
1 patient suffered a further stroke/TIA (mean follow-up 4.2 years).
Conclusion: To predict the likelihood of major stroke in symptomatic
carotid stenosis and the benefit of CEA, plaque stability and the number of
ischaemic events might be as important as an estimate of the degree of
stenosis.
Predictive Factors for In-stent Restenosis after Balloon-mounted Stent
Placement for Symptomatic Intracranial Atherosclerosis
Zhu S.G., Zhang R.L., Liu W.H., Yin Q., Zhou Z.M., Zhu W.S., Zhu Y.L.,
Xu G.L., Liu X.F. Eur J Vasc Endovasc Surg 2010;40;in press.
Objectives: We sought to evaluate whether clinical, lesion-related and
procedural factors may predict in-stent restenosis (ISR) after intracranial
stenting.
Methods: Sixty-one Chinese patients with 65 lesions treated with
single bare metal balloon-mounted stent for symptomatic intracranial arte-
rial stenosis underwent conventional angiographic follow-up after proce-
dures between March 2004 and July 2009. Clinical, lesion-related and
procedural factors were analysed for any predictive power for the ISR using
univariate andmultivariate analysis. ISR was defined as50% stenosis within
or at the edge of the stent or absolute luminal loss 20%.
Results: ISR was found in 18 patients (18/61, 29.5%) with 20 lesions
(20/65, 30.8%) at a median follow-up of 7 months (range, 5–30 months).
Univariate analysis revealed that diabetes, Mori classification, lesion length
and stent diameter were associated with ISR. In addition, diabetes (hazard
ratio (HR), 2.661; 95% confidence interval (CI), 1.044–6.787; P  0.040)
and lesion length (HR, 1.206; 95% CI, 1.023–1.421; P  0.026) were
detected as two independent predictors for ISR by stepwise multivariate Cox
regression analysis.
Conclusions: ISR after intracranial stenting with bare metal balloon-
mounted stents in our series seems to be more frequent than those reported
by the majority of the published case series. Diabetes and lesion length are
associated with increased risk of ISR.
Heterogeneity of Reporting Standards in Randomised Clinical Trials
of Endovenous Interventions for Varicose Veins
Thakur B., Shalhoub J., Hill A.M., Gohel M.S., Davies A.H. Eur J Vasc
Endovasc Surg 2010;40;in press.
Aims: The efficacy of endovenous treatments for venous reflux has
been demonstrated in numerous randomised clinical trials, although signif-
icant heterogeneity may exist between studies. The aim of this study was to
assess the heterogeneity in reporting between randomised clinical trials
investigating endovenous treatments for patients with varicose veins.
Methods: A literature search of the Pubmed, Cochrane and Google
Scholar databases was performed using appropriate search terms. Random-
ised clinical trials published between January 1968 and June 2009 evaluating
endovenous interventions for varicose veins were included and relevant
abstracts and full text articles were reviewed. Published study reports were
evaluated against recommended reporting standards published by the Amer-
ican Venous Forum in 2007.
Results: Twenty-eight randomised trials fulfilled the inclusion criteria.
Median patient age (reported in 20/28 studies) ranged from 33 to 54 years.
The CEAP classification was presented in 17/28 studies and the proportion
of patients with C2 disease ranged from 6.3% to 83.5%. A total of 31
different outcome measures were utilised. This included 13 different ques-
tionnaires, varicose vein recurrence at 38 time points and 30 categories of
complications. Duplex ultrasonography was used in 21/28 trials to assess
recurrence. Quality of life was only evaluated in 11 studies and the follow-up
period ranged from 3 weeks to 10 years.
Conclusions: Meaningful comparison across randomised studies of
endovenous treatments is made difficult by considerable variations in study
populations and outcome measures between trials. This highlights the need
for the use of prospectively agreed population selection, and reportingocular events; 28 patients had features of unstable plaque on imaging; 19
patients experienced multiple events before CEA. All had haemorrhagic,
standards for outcome measures in randomised clinical assessments of new
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